Novo Nordisk's weight loss drug, Saxenda, helped children ages six to 11 reduce their body mass index in a recent trial.

Demand for Eli Lilly’s Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily ...

Eli Lilly said it will spend $1.8 billion to boost production in Ireland of its popular diabetes and weight-loss drugs, along with ingredients for its recently approved Alzheimer’s treatment, Kisunla.

Eli Lilly has appointed Lucas Montarce as its new Chief Financial Officer, following the departure of former CFO Anat ...

The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...

Terns Pharmaceuticals this morning reported that its small molecule GLP-1 pill led to weight loss in a short Phase 1 study, ...

and Eli Lilly (Zepbound) set a high bar, but the report disagrees, arguing that the up-and-coming obesity drugs will have better efficacy, convenience and tolerability. Learn more about the future of ...

Terns Pharmaceuticals will advance TERN-601 into Phase II after early-stage data showed the oral therapy led to weight loss ...

Good morning. Eli Lilly and Company has promoted longtime executive Lucas Montarce to the role of CFO. The move is similar to ...

The new discounted single-dose formulation will likely improve access to low doses of the weight loss drug for certain ...

Noom plans to offer a compounded formulation of Novo Nordisk’s (NVO) semaglutide at discount prices as part of a new ...